[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 精选文章

International Journal of Clinical Research. 2025; 9: (6) ; 10.12208/j.ijcr.20250315 .

Clinical study on the treatment of pulmonary nodules with Guizhi Fuling pill
桂枝茯苓丸治疗肺结节的临床研究

作者: 李茁壮 *

馆陶县中医医院 河北邯郸

*通讯作者: 李茁壮,单位:馆陶县中医医院 河北邯郸;

引用本文: 李茁壮 桂枝茯苓丸治疗肺结节的临床研究[J]. 国际临床研究杂志, 2025; 9: (6) : 170-172.
Published: 2025/6/27 13:35:39

摘要

目的 探究分析桂枝茯苓丸治疗肺结节的临床效果。方法 选取2024年1月至2024年12月期间,院内肺结节患者共102例,作为此次研究对象。通过随机数表法,将102例患者随机分为对照组与观察组。对照组采用西药治疗,观察组在对照组的基础上结合桂枝茯苓丸治疗,对比两组肺功能状态,中医证候积分以及生活质量。结果 治疗前两组第1秒用力呼气容积,用力肺活量,中医证候积分以及SF-36评分对比,P>0.05。治疗后观察组第1秒用力呼气容积,用力肺活量以及SF-36评分高于对照组,中医证候积分低于对照组,P<0.05。结论 结合桂枝茯苓丸可显著改善患者肺功能状态,中医证候积分以及生活质量,值得推广与应用。

关键词: 肺结节;桂枝茯苓丸;肺功能状态;中医证候积分;生活质量

Abstract

Objective To explore and analyze the clinical efficacy of Guizhi Fuling Pill in treating pulmonary nodules.
Methods A total of 102 patients with pulmonary nodules in the hospital from January 2024 to December 2024 were selected as the study subjects. 102 patients were randomly divided into a control group and an observation group using a random number table method. The control group was treated with Western medicine, while the observation group was treated with Guizhi Fuling Pill in addition to the control group. The lung function status, TCM syndrome scores, and quality of life were compared between the two groups.
Results Comparison of forced expiratory volume in the first second, forced vital capacity, TCM syndrome score, and SF-36 score between the two groups before treatment, P>0.05. After treatment, the observation group had higher forced expiratory volume, forced vital capacity, and SF-36 score in the first second compared to the control group, while the TCM syndrome score was lower than that of the control group, P<0.05.
Conclusion   Combining Guizhi Fuling Pill can significantly improve patients' lung function status, TCM syndrome score, and quality of life, which is worthy of promotion and application.

Key words: Pulmonary nodules; Guizhi Fuling pill; Pulmonary function status; Traditional Chinese Medicine syndrome points; Quality of life

参考文献 References

[1] 中华医学会呼吸病学分会,中国肺癌防治联盟专家组.肺结节诊治中国专家共识(2024年版)[J].中华结核和呼吸杂志,2024,47(8):716-729.

[2] 张发平,周进明,杨升云,等.小青龙汤加减与艾灸联合西医治疗外寒内饮型肺结节患者的效果观察[J].大医生,2024,9(20):10-12.

[3] 彭陈文.基于数据挖掘和网络药理学探讨刘小虹教授治疗肺结节的中医药规律和作用机制[D].广州中医药大学,2024.

[4] 廖俊伍.基于“伏邪”理论辨治无肺系症状肺结节证治规律的真实世界研究[D].黑龙江中医药大学,2024.

[5] 袁欣.基于数据挖掘和网络药理学探究薛汉荣教授治疗肺结节的用药规律及核心方解析[D].江西中医药大学,2024.

[6] 梁茂新,高天舒.《中药新药临床研究指导原则》脏腑诸证考察与分析[J].中国中医基础医学杂志,2008,14(5):330-331,342.

[7] 赵园园.周大勇主任治疗“脾虚湿盛型”肺结节用药规律的数据挖掘及高频组方网络药理学研究[D].安徽中医药大学,2024.

[8] 张鑫,周钰浩,刘文华,等.基于经方化裁的消瘀散结方治疗痰瘀互结型中危肺结节的临床研究[J].广州中医药大学学报,2025,42(01):101-107.

[9] 王运华.桂昆散结方治疗寒痰阻肺型肺结节及预防其恶变的临床观察[D].三峡大学,2024.

[10] 王勤.温阳益气散结法干预阳虚痰瘀互结型肺结节(中低危)的临床疗效观察[D].云南中医药大学,2024.